Clinical Research Directory

Inclusion Criteria: one or more of the following * NYHA Class III-IV HF * NYHA Class II HF patients with elevated BNP levels (BNP\>100 pg per mL) NYHA Class II HF patients with elevated NT-proBNP levels (NT-proBNP\>400 pg per mL) * HF Patients with at least one Worsening HF event (in /out-patient) in past 12 months * HF patients with Acute Renal Failure or Chronic Kidney Disease * HF patients with Chronic Obstructive Pulmonary Disease (COPD) * HF patients currently on 40 mg or more of Furosemide / Exclusion Criteria: * Under age 60 * End Stage Renal Disease * Patients with severe COPD (GOLD stage III or IV) * Limited mobility preventing application of device * Cognitive impairments that would limit the application and proper use of the device * Skin allergies or skin sensitivities to silicone-based adhesives * Pregnancy * Skin breakdown on the left chest or breast area * Not willing to shave chest hair if needed to apply device * No cellular coverage (Patient's Home)